Inflammation and gastrointestinal Candida colonization

Current Opinion in Microbiology

Volumn 14, Issue 4, 2011, Pages 386-391

  Kumamoto, Carol A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; FLUCONAZOLE; IMMUNOMODULATING AGENT; INTERLEUKIN 17; TETRACYCLINE;

CANDIDA ALBICANS; CANDIDIASIS; CELL POPULATION; CROHN DISEASE; DIGESTIVE SYSTEM INFLAMMATION; DUODENUM ULCER; EXPERIMENTAL MODEL; FUNGAL COLONIZATION; HUMAN; INFLAMMATION; NONHUMAN; REVIEW; STOMACH ULCER; ULCER PERFORATION; ULCERATIVE COLITIS;

ANIMALS; CANDIDA ALBICANS; CYSTEAMINE; FECES; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-17; MICE; PROBIOTICS; RATS; STOMACH ULCER;

ANIMALIA; CANDIDA;

EID: 80051792725     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2011.07.015     Document Type: Review

References (63)

1. Nucci M., Anaissie E. Revisiting the source of candidemia: skin or gut?. Clin Infect Dis 2001, 33:1959-1967.
2. Odds F.C. Candida infections: an overview. Crit Rev Microbiol 1987, 15:1-5.
3. Miranda L.N., van der Heijden I.M., Costa S.F., Sousa A.P., Sienra R.A., Gobara S., Santos C.R., Lobo R.D., Pessoa V.P., Levin A.S. Candida colonisation as a source for candidaemia. J Hosp Infect 2009, 72:9-16.
4. Soll D.R., Galask R., Schmid J., Hanna C., Mac K., Morrow B. Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J Clin Microbiol 1991, 29:1702-1710.
5. Rosenbach A., Dignard D., Pierce J.V., Whiteway M., Kumamoto C.A. Adaptations of Candida albicans for growth in the mammalian intestinal tract. Eukaryot Cell 2010, 9:1075-1086.
6. Vu B., Essmann M., Larsen B. Sodium choleate (NaCho) effects on Candida albicans: implications for its role as a gastrointestinal tract inhabitant. Mycopathologia 2010, 169:183-191.
7. Helstrom P.B., Balish E. Effect of oral tetracycline, the microbial flora, and the athymic state on gastrointestinal colonization and infection of BALB/c mice with Candida albicans. Infect Immun 1979, 23:764-774.
8. De Luca A., Montagnoli C., Zelante T., Bonifazi P., Bozza S., Moretti S., D'Angelo C., Vacca C., Boon L., Bistoni F., et al. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol 2007, 179:5999-6008.
9. Del Sero G., Mencacci A., Cenci E., d'Ostiani C.F., Montagnoli C., Bacci A., Mosci P., Kopf M., Romani L. Antifungal type 1 responses are upregulated in IL-10-deficient mice. Microbes Infect 1999, 1:1169-1180.
10. Cantorna M.T., Balish E. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun 1990, 58:1093-1100.
11. Jones-Carson J., Vazquez-Torres A., Warner T., Balish E. Disparate requirement for T cells in resistance to mucosal and acute systemic candidiasis. Infect Immun 2000, 68:2363-2365.
12. Vazquez-Torres A., Jones-Carson J., Warner T., Balish E. Nitric oxide enhances resistance of SCID mice to mucosal candidiasis. J Infect Dis 1995, 172:192-198.
13. Bellocchio S., Montagnoli C., Bozza S., Gaziano R., Rossi G., Mambula S.S., Vecchi A., Mantovani A., Levitz S.M., Romani L. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004, 172:3059-3069.
14. Zelante T., De Luca A., Bonifazi P., Montagnoli C., Bozza S., Moretti S., Belladonna M.L., Vacca C., Conte C., Mosci P., et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007, 37:2695-2706.
15. Ekenna O., Sherertz R.J. Factors affecting colonization and dissemination of Candida albicans from the gastrointestinal tract of mice. Infect Immun 1987, 55:1558-1563.
16. Mellado E., Cuenca-Estrella M., Regadera J., Gonzalez M., Diaz-Guerra T.M., Rodriguez-Tudela J.L. Sustained gastrointestinal colonization and systemic dissemination by Candida albicans, Candida tropicalis and Candida parapsilosis in adult mice. Diagn Microbiol Infect Dis 2000, 38:21-28.
17. Wiesner S.M., Jechorek R.P., Garni R.M., Bendel C.M., Wells C.L. Gastrointestinal colonization by Candida albicans mutant strains in antibiotic-treated mice. Clin Diagn Lab Immunol 2001, 8:192-195.
18. Clark J.D. Influence of antibiotics or certain intestinal bacteria on orally administered Candida albicans in germ-free and conventional mice. Infect Immun 1971, 4:731-737.
19. Samonis G., Anaissie E.J., Bodey G.P. Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrob Agents Chemother 1990, 34:2420-2422.
20. Westwater C., Balish E., Warner T.F., Nicholas P.J., Paulling E.E., Schofield D.A. Susceptibility of gnotobiotic transgenic mice (Tgepsilon26) with combined deficiencies in natural killer cells and T cells to wild-type and hyphal signalling-defective mutants of Candida albicans. J Med Microbiol 2007, 56:1138-1144.
21. Sundstrom P., Balish E., Allen C.M. Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice. J Infect Dis 2002, 185:521-530.
22. White S.J., Rosenbach A., Lephart P., Nguyen D., Benjamin A., Tzipori S., Whiteway M., Mecsas J., Kumamoto C.A. Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog 2007, 3:e184.
23. Kim A.S., Garni R.M., Henry-Stanley M.J., Bendel C.M., Erlandsen S.L., Wells C.L. Hypoxia and extraintestinal dissemination of Candida albicans yeast forms. Shock 2003, 19:257-262.
24. Montagnoli C., Bacci A., Bozza S., Gaziano R., Mosci P., Sharpe A.H., Romani L. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol 2002, 169:6298-6308.
25. Standaert-Vitse A., Sendid B., Joossens M., Francois N., Vandewalle-El Khoury P., Branche J., Van Kruiningen H., Jouault T., Rutgeerts P., Gower-Rousseau C., et al. Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol 2009, 104:1745-1753.
26. Esters N., Pierik M., van Steen K., Vermeire S., Claessens G., Joossens S., Vlietinck R., Rutgeerts P. Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. Am J Gastroenterol 2004, 99:299-305.
27. Mei L., Targan S.R., Landers C.J., Dutridge D., Ippoliti A., Vasiliauskas E.A., Papadakis K.A., Fleshner P.R., Rotter J.I., Yang H. Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease. Gastroenterology 2006, 130:1078-1085.
28. Sendid B., Quinton J.F., Charrier G., Goulet O., Cortot A., Grandbastien B., Poulain D., Colombel J.F. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 1998, 93:1306-1310.
29. Sutton C.L., Yang H., Li Z., Rotter J.I., Targan S.R., Braun J. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000, 46:58-63.
30. May G.R., Sutherland L.R., Meddings J.B. Is small intestinal permeability really increased in relatives of patients with Crohn's disease?. Gastroenterology 1993, 104:1627-1632.
31. Peeters M., Geypens B., Claus D., Nevens H., Ghoos Y., Verbeke G., Baert F., Vermeire S., Vlietinck R., Rutgeerts P. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 1997, 113:802-807.
32. Kraus T.A., Cheifetz A., Toy L., Meddings J.B., Mayer L. Evidence for a genetic defect in oral tolerance induction in inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:82-88. discussion 81.
33. Ksiadzyna D., Semianow-Wejchert J., Nawrot U., Wlodarczyk K., Paradowski L. Serum concentration of interleukin 10, anti-mannan Candida antibodies and the fungal colonization of the gastrointestinal tract in patients with ulcerative colitis. Adv Med Sci 2009, 54:170-176.
34. Zwolinska-Wcislo M., Brzozowski T., Budak A., Kwiecien S., Sliwowski Z., Drozdowicz D., Trojanowska D., Rudnicka-Sosin L., Mach T., Konturek S.J., et al. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. J Physiol Pharmacol 2009, 60:107-118.
35. Morishita T., Kamiya T., Munakata Y., Tsuchiya M. Radiologic and endoscopic studies of gastric ulcers associated with Candida infection. Acta Gastroent Latinoamer 1993, 23:223-229.
36. Goenka M.K., Kochhar R., Chakrabarti A., Kumar A., Gupta O., Talwar P., Mehta S.K. Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole. J Clin Gastroenterol 1996, 23:7-10.
37. Zwolinska-Wcislo M., Brzozowski T., Mach T., Budak A., Trojanowska D., Konturek P.C., Pajdo R., Drozdowicz D., Kwiecien S. Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J Physiol Pharmacol 2006, 57(Suppl. 9):35-49.
38. Nakamura T., Yoshida M., Ishikawa H., Kameyama K., Wakabayashi G., Otani Y., Shimazu M., Tanabe M., Kawachi S., Kumai K., et al. Candida albicans aggravates duodenal ulcer perforation induced by administration of cysteamine in rats. J Gastroenterol Hepatol 2007, 22:749-756.
39. Jin L., Yoshida M., Nakamura T., Ishikawa H., Wakabayashi G., Tanabe M., Kawachi S., Shinoda M., Saikawa Y., Wada N., et al. Candida albicans infection delays duodenal ulcer healing in cysteamine-induced duodenal ulcers in rats. Dig Dis Sci 2008, 53:2878-2885.
40. Brzozowski T., Zwolinska-Wcislo M., Konturek P.C., Kwiecien S., Drozdowicz D., Konturek S.J., Stachura J., Budak A., Bogdal J., Pawlik W.W., et al. Influence of gastric colonization with Candida albicans on ulcer healing in rats: effect of ranitidine, aspirin and probiotic therapy. Scand J Gastroenterol 2005, 40:286-296.
41. Jawhara S., Thuru X., Standaert-Vitse A., Jouault T., Mordon S., Sendid B., Desreumaux P., Poulain D. Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J Infect Dis 2008, 197:972-980.
42. Stecher B., Robbiani R., Walker A.W., Westendorf A.M., Barthel M., Kremer M., Chaffron S., Macpherson A.J., Buer J., Parkhill J., et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 2007, 5:2177-2189.
43. Rutgeerts P., Goboes K., Peeters M., Hiele M., Penninckx F., Aerts R., Kerremans R., Vantrappen G. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991, 338:771-774.
44. Stepankova R., Powrie F., Kofronova O., Kozakova H., Hudcovic T., Hrncir T., Uhlig H., Read S., Rehakova Z., Benada O., et al. Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RBhigh CD4+ T cells. Inflamm Bowel Dis 2007, 13:1202-1211.
45. Sands B.E. Inflammatory bowel disease: past, present, and future. J Gastroenterol 2007, 42:16-25.
46. Card T., Logan R.F., Rodrigues L.C., Wheeler J.G. Antibiotic use and the development of Crohn's disease. Gut 2004, 53:246-250.
47. Hovhannisyan Z., Treatman J., Littman D.R., Mayer L. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 2010, 140:957-965.
48. Shen W., Durum S.K. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease. Neurochem Res 2010, 35:940-946.
49. Sarra M., Pallone F., Macdonald T.T., Monteleone G. IL-23/IL-17 axis in IBD. Inflamm Bowel Dis 2010, 16:1808-1813.
50. Zhang Z., Rosenbaum J.T., Zhong W., Lim C., Hinrichs D.J. Costimulation of Th17 cells: adding fuel or putting out the fire in the inflamed gut?. Semin Immunopathol 2010, 32:55-70.
51. Liu Z.J., Yadav P.K., Su J.L., Wang J.S., Fei K. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 2009, 15:5784-5788.
52. Veny M., Esteller M., Ricart E., Pique J.M., Panes J., Salas A. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Aliment Pharmacol Ther 2010, 31:561-572.
53. Rovedatti L., Kudo T., Biancheri P., Sarra M., Knowles C.H., Rampton D.S., Corazza G.R., Monteleone G., Di Sabatino A., Macdonald T.T. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut 2009, 58:1629-1636.
54. Seiderer J., Elben I., Diegelmann J., Glas J., Stallhofer J., Tillack C., Pfennig S., Jurgens M., Schmechel S., Konrad A., et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 2008, 14:437-445.
55. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., Bamba T., Fujiyama Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003, 52:65-70.
56. Mizuno T., Ando T., Nobata K., Tsuzuki T., Maeda O., Watanabe O., Minami M., Ina K., Kusugami K., Peek R.M., et al. Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization. World J Gastroenterol 2005, 11:6305-6311.
57. Hue S., Ahern P., Buonocore S., Kullberg M.C., Cua D.J., McKenzie B.S., Powrie F., Maloy K.J. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 2006, 203:2473-2483.
58. Kullberg M.C., Jankovic D., Feng C.G., Hue S., Gorelick P.L., McKenzie B.S., Cua D.J., Powrie F., Cheever A.W., Maloy K.J., et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med 2006, 203:2485-2494.
59. Yen D., Cheung J., Scheerens H., Poulet F., McClanahan T., McKenzie B., Kleinschek M.A., Owyang A., Mattson J., Blumenschein W., et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006, 116:1310-1316.
60. Conti H.R., Shen F., Nayyar N., Stocum E., Sun J.N., Lindemann M.J., Ho A.W., Hai J.H., Yu J.J., Jung J.W., et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009, 206:299-311.
61. Saunus J.M., Wagner S.A., Matias M.A., Hu Y., Zaini Z.M., Farah C.S. Early activation of the interleukin-23-17 axis in a murine model of oropharyngeal candidiasis. Mol Oral Microbiol 2010, 25:343-356.
62. Nakamura T., Yoshida M., Otani Y., Kameyama K., Ishikawa H., Kumai K., Kubota T., Saikawa Y., Kitajima M. Twelve years' progress in surgery for perforated gastric and duodenal ulcers: a retrospective study of indications for laparoscopic surgery, post-operative course and the influence of Candida infection. Aliment Pharmacol Ther 2006, 24(Suppl. 4):297-302.
63. Lee S.C., Fung C.P., Chen H.Y., Li C.T., Jwo S.C., Hung Y.B., See L.C., Liao H.C., Loke S.S., Wang F.L., et al. Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B. Diagn Microbiol Infect Dis 2002, 44:23-27.